International Peer-Reviewed Journal•Open Access•ISSN 2456-8880
irejournals@gmail.com•+91-7433024337

Home / Current Issue / Paper 1718797

1718797 Vol 9 · Issue 12 Download Paper

Formulation and Development of Oro-Topical Emulgel Containing Clotrimazole Using Turmeric (Curcuma longa) as an Adjuvant

Mahi Patel Madhuri Dubey

Subject area: Science,Engineering and Technology  ·  Area of research: Pharmacy

DOI: 10.64388/IREV9I12-1718797

Abstract

Oropharyngeal candidiasis remains a significant fungal infection affecting both immunocompetent and immunocompromised individuals, necessitating effective and patient-compliant topical drug delivery systems. The present study describes the formulation and development of an oro-topical emulgel incorporating clotrimazole (1% w/w) as the principal antifungal agent and turmeric extract (Curcuma longa) as a natural adjuvant, using Carbopol 934 as the gelling agent. Nine formulations (F1–F9) were prepared by systematically varying the concentrations of Carbopol 934 (0.5–1.5%), turmeric extract (0.5–2.5%), and liquid paraffin (5–10%) while maintaining fixed concentrations of Span 80, Tween 80, propylene glycol, and preservatives. The formulations were evaluated for physical appearance, pH, viscosity, spreadability, drug content uniformity, in-vitro drug release, and stability under ICH guidelines. Preformulation studies confirmed the purity, physicochemical properties, and compatibility of clotrimazole with selected excipients through FTIR spectroscopy, melting point determination, and solubility analysis. All formulations exhibited a yellowish, homogeneous appearance with no phase separation. The optimized formulation F5 demonstrated a pH of 6.38±0.02, viscosity of 10,120±110 cps, spreadability of 6.05±0.09 g·cm/sec, drug content of 96.5±0.5%, and maximum cumulative drug release of 94.6±1.0% over 8 hours. Stability studies confirmed that F5 retained its physicochemical integrity over 90 days under accelerated conditions. The results suggest that the developed emulgel system represents a promising, effective, and biocompatible oro-topical delivery platform for the treatment of oral fungal infections.

Keywords

Emulgel, Clotrimazole, Curcuma Longa, Turmeric, Oro-Topical, Carbopol 934, Antifungal, Drug Delivery, Mucoadhesive, In-Vitro Release

References

[1] Liu, L., Javed, H. U., & Xiao, J. (2022). Engineering emulsion gels as functional colloids emphasizing food applications: A review. Frontiers in Nutrition, 9, 890188.

[2] Lu, Y., Mao, L., Hou, Z., Miao, S., & Gao, Y. (2019). Development of emulsion gels for the delivery of functional food ingredients: From structure to functionality. Food Engineering Reviews, 11, 245–258.

[3] Dickinson, E. (2012). Emulsion gels: The structuring of soft solids with protein-stabilized oil droplets. Food Hydrocolloids, 28, 224–241.

[4] Lu, Y., Zhang, Y., Yuan, F., Gao, Y., & Mao, L. (2021). Emulsion gels with different proteins at the interface: Structures and delivery functionality. Food Hydrocolloids, 116, 106637.

[5] Sharma, V., Nayak, S. K., Paul, S. R., Choudhary, B., Ray, S. S., & Pal, K. (2018). Emulgels. In K. Pal & I. Banerjee (Eds.), Polymeric Gels (pp. 251–264). Woodhead Publishing, Sawston, UK.

[6] Patil, P. B., Datir, S. K., & Saudagar, R. B. (2019). A review on topical gels as drug delivery system. Journal of Drug Delivery and Therapeutics, 9, 989–994.

[7] Dubey, A., Prabhu, P., & Kamath, J. V. (2012). Nano structured lipid carriers: A novel topical drug delivery system. International Journal of PharmTech Research, 4, 705–714.

[8] Fishman, M. L., Chau, H. K., Hoagland, P. D., & Hotchkiss, A. T. (2008). Pectin-based model food systems for controlled release. Journal of Agricultural and Food Chemistry, 56(17), 8300–8305.

[9] Ammon, H. P., & Wahl, M. A. (1991). Pharmacology of Curcuma longa. Planta Medica, 57, 1–10.

[10] Corstens, M. N., Berton-Carabin, C. C., Elichiry-Ortiz, P. T., Hol, K., Troost, F. J., Masclee, A. A., & Schroen, K. (2017). Emulsion-alginate beads designed to control in vitro intestinal lipolysis: Towards appetite control. Journal of Functional Foods, 34, 319–328.

[11] Guo, Q., Ye, A., Bellissimo, N., Singh, H., & Rousseau, D. (2017). Modulating fat digestion through food structure design. Progress in Lipid Research, 68, 109–118.

[12] Kumar, S., Jain, A., & Verma, P. (2020). Development of NSAID-loaded oral gels for gingivitis treatment. International Journal of Pharmaceutical Sciences and Research, 11(4), 456–463.

[13] Sharma, R., Singh, V., & Gupta, A. (2019). Role of citrus pectin in stabilizing emulsions for drug delivery. Journal of Pharmaceutical and Biomedical Sciences, 8(3), 120–125.

[14] Gupta, P. K., Dubey, R., & Singh, S. (2021). Naproxen gels for periodontal therapy: Formulation and evaluation. Journal of Dental Research, 10(2), 34–40.

[15] Reddy, S., Rao, M., & Desai, P. (2017). Formulation and evaluation of dental emulgels. Asian Journal of Pharmaceutics, 11(3), 194–200.

[16] Kathpalia, H., Venkatesh, A., & Sathe, N. (2023). Film forming clotrimazole emulgel. Indian Journal of Pharmaceutical Education and Research, 57(2S), S250–S261.

[17] Kaur, L. P., & Singh, R. (2022). Formulation and evaluation of clotrimazole emulgel. Asian Journal of Pharmaceutical Sciences, 17(2).

[18] Usha, A. L., Bhavani, A. V. S., Vardhan, K. V., et al. (2025). Preparation and evaluation of clotrimazole emulgel using Carbopol as gelling agent.

[19] Jyothi, V., Pullemla, M., Nafiroona, S., et al. (2022). Formulation and evaluation of curcumin emulgel. Journal of Pharmacognosy and Phytochemistry, 11(6), 33–41.

[20] Ghosh, V., Mukherjee, A., & Chandrasekaran, N. (2023). Curcumin nanoemulgel for anti-inflammatory activity. Colloids and Surfaces B: Biointerfaces, 223, 113–210.

[21] Rai, M., Yadav, A., & Singh, D. (2024). Herbal emulgel of Curcuma longa for anti-inflammatory activity. Journal of Ethnopharmacology, 305, 116089.

[22] Razdan, K., Kanta, S., Chaudhary, E., et al. (2023). Levofloxacin-loaded nanoemulgel for wound healing. Colloids and Surfaces B: Biointerfaces, 222, 111119.

[23] Kumar, A., Verma, R., Pal, K., et al. (2022). Quality by design approach for diclofenac emulgel development. Research Journal of Pharmacy and Technology, 15(7).

[24] Bhatia, G., Zhou, Y., & Bansal, V. (2023). Emulgels: Recent advances in topical drug delivery. Pharmaceutics, 15(3).

[25] Beckett, A. H., & Stenlake, J. B. (2004). Practical Pharmaceutical Chemistry. CBS Publishers.

[26] United States Pharmacopeial Convention. (2020). United States Pharmacopeia and National Formulary (USP 43–NF 38). United States Pharmacopeial Convention.

[27] Indian Pharmacopoeia Commission. (2018). Indian Pharmacopoeia (7th ed.).

[28] Harborne, J. B. (1998). Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. Springer.

[29] Kokate, C. K., Purohit, A. P., & Gokhale, S. B. (2010). Practical Pharmacognosy (5th ed.). Vallabh Prakashan.

[30] Singh, A., Kaur, H., & Sharma, P. (2018). Characterization of beet root pectin for pharmaceutical applications. Carbohydrate Polymers, 190, 312–318.

[31] Patel, R., Joshi, N., & Shah, V. (2022). Oro-dispersible gels of naproxen for gum disease treatment. International Journal of Advanced Pharmaceutical Research, 13(5), 77–84.

[32] Bhardwaj, P., Tripathi, P., & Gupta, R. (2020). Formulation of NSAID emulgel for topical applications. Journal of Pharmaceutical Sciences and Research, 12(6), 746–752.

[33] Mishra, A., Verma, K., & Prakash, A. (2019). Naproxen-loaded emulgels for periodontal therapy. International Journal of Pharmaceutical Investigation, 9(2), 85–90.

[34] Mutimer, M. N. (1956). Spreadability determination methods in semisolid formulations. Journal of Pharmacy and Pharmacology, 8, 1–10.

[35] Joshi, M., Patel, S., & Kumar, H. (2021). Sustained release emulgel for oral care applications. Advanced Drug Delivery Reviews, 180, 113–122.

[36] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (2003). ICH Q1A(R2): Stability Testing of New Drug Substances and Products.

[37] Higuchi, T. (1963). Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences, 52, 1145–1149.

How to cite this paper

Mahi Patel, Madhuri Dubey "Formulation and Development of Oro-Topical Emulgel Containing Clotrimazole Using Turmeric (Curcuma longa) as an Adjuvant" Iconic Research And Engineering Journals Volume 9 Issue 12 2026 Page 924-935 https://doi.org/10.64388/IREV9I12-1718797
Mahi Patel, Madhuri Dubey "Formulation and Development of Oro-Topical Emulgel Containing Clotrimazole Using Turmeric (Curcuma longa) as an Adjuvant" Iconic Research And Engineering Journals, vol. 9, no. 12, Jun. 2026, doi: https://doi.org/10.64388/IREV9I12-1718797
Mahi Patel, Madhuri Dubey (2026). Formulation and Development of Oro-Topical Emulgel Containing Clotrimazole Using Turmeric (Curcuma longa) as an Adjuvant. Iconic Research And Engineering Journals, 9(12). doi: https://doi.org/10.64388/IREV9I12-1718797
Mahi Patel, Madhuri Dubey "Formulation and Development of Oro-Topical Emulgel Containing Clotrimazole Using Turmeric (Curcuma longa) as an Adjuvant" Iconic Research And Engineering Journals, vol. 9, no. 12, Jun. 2026. Crossref, https://doi.org/10.64388/IREV9I12-1718797
@article{1718797,
      author = {Mahi Patel, Madhuri Dubey},
      title = {Formulation and Development of Oro-Topical Emulgel Containing Clotrimazole Using Turmeric (Curcuma longa) as an Adjuvant},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {12},
      pages = {924-935},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1718797.pdf},
      abstract = {Oropharyngeal candidiasis remains a significant fungal infection affecting both immunocompetent and immunocompromised individuals, necessitating effective and patient-compliant topical drug delivery systems. The present study describes the formulation and development of an oro-topical emulgel incorporating clotrimazole (1% w/w) as the principal antifungal agent and turmeric extract (Curcuma longa) as a natural adjuvant, using Carbopol 934 as the gelling agent. Nine formulations (F1–F9) were prepared by systematically varying the concentrations of Carbopol 934 (0.5–1.5%), turmeric extract (0.5–2.5%), and liquid paraffin (5–10%) while maintaining fixed concentrations of Span 80, Tween 80, propylene glycol, and preservatives. The formulations were evaluated for physical appearance, pH, viscosity, spreadability, drug content uniformity, in-vitro drug release, and stability under ICH guidelines. Preformulation studies confirmed the purity, physicochemical properties, and compatibility of clotrimazole with selected excipients through FTIR spectroscopy, melting point determination, and solubility analysis. All formulations exhibited a yellowish, homogeneous appearance with no phase separation. The optimized formulation F5 demonstrated a pH of 6.38±0.02, viscosity of 10,120±110 cps, spreadability of 6.05±0.09 g·cm/sec, drug content of 96.5±0.5%, and maximum cumulative drug release of 94.6±1.0% over 8 hours. Stability studies confirmed that F5 retained its physicochemical integrity over 90 days under accelerated conditions. The results suggest that the developed emulgel system represents a promising, effective, and biocompatible oro-topical delivery platform for the treatment of oral fungal infections.},
      keywords = {Emulgel, Clotrimazole, Curcuma Longa, Turmeric, Oro-Topical, Carbopol 934, Antifungal, Drug Delivery, Mucoadhesive, In-Vitro Release},
      month = {June},
      doi = {https://doi.org/10.64388/IREV9I12-1718797}
  }